Patents Assigned to Prolacta Bioscience, Inc.
-
Patent number: 11805785Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.Type: GrantFiled: December 13, 2019Date of Patent: November 7, 2023Assignee: Prolacta Bioscience, Inc.Inventors: Joseph Fournell, Scott Eaker, Armando Montoya
-
Patent number: 11419342Abstract: The disclosure features a human milk cream composition as well as methods of making a human milk cream composition and using a human milk cream composition. In particular, the disclosure features a method of using a human milk cream composition to raise the caloric content of human milk.Type: GrantFiled: May 15, 2019Date of Patent: August 23, 2022Assignee: Prolacta BioScience, Inc.Inventors: Scott Elster, Joseph Fournell, Scott Eaker
-
Publication number: 20220232844Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.Type: ApplicationFiled: April 12, 2022Publication date: July 28, 2022Applicant: Prolacta Bioscience, Inc.Inventors: Elena M. MEDO, Armando MONTOYA, Martin LEE, David RECHTMAN
-
Patent number: 11344041Abstract: The present disclosure relates to human milk compositions and methods of making and using the same. In particular, the disclosure features methods of using human milk compositions to feed subjects before and/or after surgery or medical operations and that are useful in promoting recovery.Type: GrantFiled: December 29, 2016Date of Patent: May 31, 2022Assignee: PROLACTA BIOSCIENCE, INC.Inventors: Scott Elster, Joseph Fournell
-
Patent number: 11122813Abstract: The disclosure features a human milk cream composition as well as methods of making a human milk cream composition and using a human milk cream composition. In particular, the disclosure features a method of using a human milk cream composition to raise the caloric content of human milk.Type: GrantFiled: March 5, 2014Date of Patent: September 21, 2021Assignee: Prolacta Bioscience, Inc.Inventors: Scott Elster, Joseph Fournell, Scott Eaker
-
Publication number: 20200359642Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.Type: ApplicationFiled: December 13, 2019Publication date: November 19, 2020Applicant: Prolacta Bioscience, Inc.Inventors: Joseph FOURNELL, Scott EAKER, Armando MONTOYA
-
Patent number: 10820604Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.Type: GrantFiled: August 3, 2012Date of Patent: November 3, 2020Assignee: Prolacta Bioscience, Inc.Inventors: Joseph Fournell, Scott Eaker, Armando Montoya
-
Patent number: 10506818Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.Type: GrantFiled: October 17, 2017Date of Patent: December 17, 2019Assignee: Prolacta Bioscience, Inc.Inventors: Joseph Fournell, Scott Eaker, Armando Montoya
-
Publication number: 20190327994Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.Type: ApplicationFiled: July 8, 2019Publication date: October 31, 2019Applicant: Prolacta Bioscience, Inc.Inventors: Elena M. MEDO, Armando MONTOYA, Martin LEE, David RECHTMAN
-
Publication number: 20190090501Abstract: The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.Type: ApplicationFiled: November 14, 2018Publication date: March 28, 2019Applicant: Prolacta Bioscience, Inc.Inventors: Elena M. Medo, Martin L. Lee, David J. Rechtman, Joseph Fournell
-
Publication number: 20190075809Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.Type: ApplicationFiled: November 14, 2018Publication date: March 14, 2019Applicant: Prolacta Bioscience, Inc.Inventors: Elena M. MEDO, Armando MONTOYA, Martin LEE, David RECHTMAN
-
Publication number: 20190075808Abstract: The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.Type: ApplicationFiled: November 14, 2018Publication date: March 14, 2019Applicant: Prolacta Bioscience, Inc.Inventors: Elena M. MEDO, Martin L. LEE, David J. RECHTMAN, Joseph FOURNELL
-
Publication number: 20190053508Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.Type: ApplicationFiled: October 24, 2018Publication date: February 21, 2019Applicant: Prolacta Bioscience, Inc.Inventors: Elena M. MEDO, Armando MONTOYA, Martin LEE, David RECHTMAN
-
Publication number: 20180092374Abstract: This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease.Type: ApplicationFiled: October 5, 2017Publication date: April 5, 2018Applicant: Prolacta Bioscience, Inc.Inventors: Joseph FOURNELL, Scott EAKER, Scott ELSTER, David J. RECHTMAN
-
Publication number: 20180042255Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.Type: ApplicationFiled: October 17, 2017Publication date: February 15, 2018Applicant: Prolacta Bioscience, Inc.Inventors: Joseph FOURNELL, Scott EAKER, Armando MONTOYA
-
Patent number: 9149052Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.Type: GrantFiled: August 30, 2007Date of Patent: October 6, 2015Assignee: PROLACTA BIOSCIENCE, INC.Inventors: Elena M. Medo, Armando Montoya, Martin Lee, David Rechtman
-
Patent number: 8821878Abstract: The disclosure features methods of making compositions that include a human lipid. The methods can include: obtaining whole human milk; separating the milk into a cream portion and a skim portion; processing the cream portion; and pasteurizing the processed cream portion.Type: GrantFiled: January 14, 2013Date of Patent: September 2, 2014Assignee: Prolacta Bioscience, Inc.Inventors: Elena M. Medo, Scott Eaker
-
Publication number: 20140093634Abstract: The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.Type: ApplicationFiled: July 19, 2013Publication date: April 3, 2014Applicant: Prolacta Bioscience, Inc.Inventors: Elena M. Medo, Martin L. Lee, David J. Rechtman, Joseph Fournell
-
Patent number: 8628921Abstract: The disclosure is related generally to methods for testing mammary fluid (including milk) to establish or confirm the identity of the donor of the mammary fluid. Such methods are useful in the milk-bank business to improve safety.Type: GrantFiled: August 23, 2012Date of Patent: January 14, 2014Assignee: Prolacta Bioscience Inc.Inventors: Elena M. Medo, Martin L. Lee, David J. Rechtman
-
Patent number: RE48240Abstract: The disclosure is related generally to methods for testing mammary fluid (including milk) to establish or confirm the identity of the donor of the mammary fluid. Such methods are useful in the milk-bank business to improve safety.Type: GrantFiled: September 10, 2018Date of Patent: October 6, 2020Assignee: Prolacta Bioscience, Inc.Inventors: Elena M. Medo, Martin L. Lee, David J. Rechtman
